Suppr超能文献

[华氏巨球蛋白血症的分子基础]

[Molecular basis of Waldenström macroglobulinemia].

作者信息

Sevčíková S, Novák L, Kubiczková L, Dementyeva E, Ríhová L, Hájek R

机构信息

Babakova myelomova skupina, Ustav patologicke fyziologie, Kamenice, Brno.

出版信息

Klin Onkol. 2012;25(6):413-20.

Abstract

Waldenström macroglobulinemia is a rare lymphoproliferative disease that is currently classified into lymphomas with incidence of 3 cases per million. This disease comprises about 1-2% of hematological malignancies and is characterized by infiltration of malignant B cells into the bone marrow and presence of monoclonal immunoglobulin IgM in serum. WM is still an incurable disease with median survival of 5 years. Molecular basis of this disease remains unclear even though deletion of 6q, trisomy of chromosomes 4 and 8, deletion of 13q and increased expression of IL-6 seem to be typical for this disease. The most important changes of microRNA are increased expression of miR-155 and decreased expression of miR-9*. This work aims to describe current knowledge about the molecular basis of this disease.

摘要

华氏巨球蛋白血症是一种罕见的淋巴增殖性疾病,目前被归类为淋巴瘤,发病率为百万分之三。这种疾病约占血液系统恶性肿瘤的1%-2%,其特征是恶性B细胞浸润骨髓以及血清中存在单克隆免疫球蛋白IgM。华氏巨球蛋白血症仍然是一种无法治愈的疾病,中位生存期为5年。尽管6q缺失、染色体4和8三体、13q缺失以及IL-6表达增加似乎是这种疾病的典型特征,但该疾病的分子基础仍不清楚。微小RNA最重要的变化是miR-155表达增加和miR-9*表达降低。这项工作旨在描述关于这种疾病分子基础的当前知识。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验